Enzo Biochem, Inc. (ENZ) Widens Q4 Loss to 69c/Share
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Clinical laboratory services: 18.56M
Today's EPS Names:
ALZN, ASPU, USAU, More
Financial Fact:
Clinical laboratory services: 18.56M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Enzo Biochem, Inc. (NYSE: ENZ) reported Q4 EPS of ($0.69), versus ($0.11) reported last year. Revenue for the quarter came in at $26.4 million, versus $26.8 million reported last year.
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- Physician-Owned, Physician-Led Medical Spa Brand Healthy Solutions Medspa Launches Franchise for Doctors
- Faraday Future says it regained Nasdaq compliance after equity shortfall
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
